QuadraMed Corporation Announces Effectiveness of One-for-Five Reverse Stock Split

  
    
  
  
    
      QuadraMed Corporation (Amex:QD) today announces the effectiveness of the 
      reverse split of its common stock in the ratio of one-for-five (the “Reverse 
      Split”). The Reverse Split was previously 
      approved by the Company’s stockholders at the 
      Annual Meeting of Stockholders of QuadraMed Corporation (the “Annual 
      Meeting”) held on June 5, 2008, and 
      subsequently approved by the Board of Directors of QuadraMed Corporation 
      at a meeting held immediately following the Annual Meeting. The Company’s 
      common stock will begin trading at the market opening on June 16, 2008 
      on a split-adjusted basis on the American Stock Exchange under its 
      current stock symbol QD.
    
    
      As previously discussed in the proxy materials for the Annual Meeting, 
      the Company’s primary purpose for effecting 
      the Reverse Split is to increase the market price of the Company’s 
      common stock in order to meet the $5.00 per share minimum share price 
      requirements for potential listing on the NASDAQ Global Market (the “NASDAQ”).
    
    
      “We believe that listing on the NASDAQ is in 
      the best interest of our stockholders,” said 
      QuadraMed President and CEO, Keith Hagen. “Many 
      of our competitors are listed on the NASDAQ, and we feel that the NASDAQ 
      offers greater visibility and increased trading volume for the Company’s 
      common stock.”
    
    
      The Company has previously filed a listing application with the NASDAQ 
      and believes that its common stock will be approved for listing in the 
      near future, at which time the Company will de-list its common stock 
      from the American Stock Exchange. However, there can be no assurance 
      that the Company’s common stock will be 
      accepted for listing on NASDAQ.
    
    
      About QuadraMed Corporation
    
    
      QuadraMed Corporation advances the success of healthcare organizations 
      through IT solutions that leverage quality care into positive financial 
      outcomes. QuadraMed provides real world solutions that help healthcare 
      professionals deliver outstanding patient care efficiently and cost 
      effectively. Behind the company’s products 
      and services is a staff of 650 professionals whose experience and 
      dedication have earned QuadraMed the trust and loyalty of clients at 
      over 2,000 healthcare provider facilities. For more information about 
      QuadraMed, visit http://www.quadramed.com.
    
    
      Cautionary Statement on Risks Associated with QuadraMed 
      Forward-Looking Statements
    
    
      This press release contains forward-looking statements within the 
      meaning of the Private Securities Litigation Reform Act of 1995 by 
      QuadraMed that are subject to risks and uncertainties. The words 
      "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," 
      "should," "could," and similar expressions are intended to identify such 
      statements. Forward-looking statements are not guarantees of future 
      performance and are to be interpreted only as of the date on which they 
      are made. QuadraMed undertakes no obligation to update or revise any 
      forward-looking statement except as required by law. QuadraMed advises 
      investors that it discusses risk factors and uncertainties that could 
      cause QuadraMed’s actual results to differ 
      from forward-looking statements in its periodic reports filed with the 
      Securities and Exchange Commission ("SEC"). QuadraMed’s 
      SEC filings can be accessed through the Investor Relations section of 
      our website, www.quadramed.com, 
      or through the SEC’s EDGAR Database at www.sec.gov 
      (QuadraMed has EDGAR CIK No. 0001018833).
    
    
      QuadraMed is a registered trademark of QuadraMed Corporation. All other 
      trademarks are the property of their respective holders.